Aggression, suicidality, and intermittent explosive disorder: Serotonergic correlates in personality disorder and healthy control subjects

Neuropsychopharmacology

Volumn 35, Issue 2, 2010, Pages 435-444

  Coccaro, Emil F ^a   Lee, Royce ^a   Kavoussi, Richard J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

5 HT; Aggression; D Fenfluramine; IED; Impulsivity; Suicidality

Indexed keywords

DEXFENFLURAMINE; PROLACTIN;

ADULT; AGGRESSION; ARTICLE; AUTOMUTILATION; BORDERLINE STATE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXTRAVERSION; FEMALE; HORMONE RESPONSE; HUMAN; IMPULSIVENESS; INTERMITTENT EXPLOSIVE DISORDER; MAJOR CLINICAL STUDY; MALE; NEUROSIS; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOPATHY; PSYCHOSIS; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT;

ADULT; AGGRESSION; ANALYSIS OF VARIANCE; FEMALE; FENFLURAMINE; HUMANS; IMPULSE CONTROL DISORDERS; MALE; PERSONALITY DISORDERS; PSYCHIATRIC STATUS RATING SCALES; SELF-INJURIOUS BEHAVIOR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 72449181285     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.148     Document Type: Article

References (56)

1. Albinsson A, Palazidou E, Stephenson J, Andersson G (1994). Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release. Eur J Pharmacol 251: 157-161.
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders 4th edn. American Psychiatric Association Press: Washington, DC.
3. Asberg M, Traskman L, Thoren P (1976). 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33: 1193-1197.
4. Barratt E (1985). Impulsiveness defined within a systems model of personality. Erlbaum: Hillsdale, NJ.
5. Ben-Jonathan N, Arbogast LA, Hyde JF (1989). Neuroendocrine [corrected] regulation of prolactin release. Prog Neurobiol 33: 399-447.
6. Berman ME, Fallon AE, Coccaro EF (1998). The relationship between personality psychopathology and aggressive behavior in research volunteers. J Abnorm Psychol 107: 651-658.
7. Botchin MB, Kaplan JR, Manuck SB, Mann JJ (1993). Low versus high prolactin responders to fenfluramine challenge: Marker of behavioral differences in adult male cynmolgus macaques. Neuropsychopharmacology 9: 93-99.
8. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979). Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1: 131-139.
9. Bunce SC, Noblett KL, McCloskey MS, Coccaro EF (2005). High prevalence of personality disorders among healthy volunteers for research: implications for control group bias. J Psychiatr Res 39: 421-430.
10. Buss AH, Durkee A (1957). An inventory for assessing different kinds of hostility. J Consult Psychol 21: 343-349.
11. Coccaro E, Siever L (2002). Pathophysiology and treatment of aggression. Psychopharmacology: the Fifth Generation of Progress 1709-1723.
12. Coccaro EF (2003). Intermittent explosive disorder. In: Coccaro EF (ed). Aggression: Psychiatric Assessment and Treatment. Marcel Dekker Inc.: New York. pp 149-166.
13. Coccaro EF, Kavoussi RJ (1994). The neuropsychopharmacologic challenge in biological psychiatry. Clin Chem 40: 319-327.
14. Coccaro EF, Kavoussi RJ, Berman ME, Lish JD (1998a). Intermittent explosive disorder-revised: development, reliability, and validity of research criteria. Compr Psychiatry 39: 368-376.
15. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger R (1996a). 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects. Psychopharmacology (Berl) 127: 108-112. (Pubitemid 26298007)
16. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger R (1998b). Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects. Psycho-pharmacology (Berl) 138: 9-15.
17. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL (1996b). Hormonal responses to d-and d,l-fenfluramine in healthy human subjects. Neuropsychopharmacology 15: 595-607.
18. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL (1997a). Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry 154: 1430-1435.
19. Coccaro EF, Kavoussi RJ, Oakes M, Cooper TB, Hauger R (1996c). 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects. Psychopharmacology (Berl) 126: 24-30.
20. Coccaro EF, Kavoussi RJ, Sheline YI, Lish JD, Csernansky JG (1996d). Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry 53: 531-536.
21. Coccaro EF, Kavoussi RJ, Trestman RL, Gabriel SM, Cooper TB, Siever LJ (1997b). Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res 73: 1-14.
22. Coccaro EF, Lee RJ, Kavoussi RJ (2009). A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. J Clin Psychiatry 70: 653-662.
23. Coccaro EF, Schmidt CA, Samuels JF, Nestadt G (2004). Lifetime and 1-month prevalence rates of intermittent explosive disorder in a community sample. J Clin Psychiatry 65(6): 820-824.
24. Coccaro EF, Siever LJ (2005). Neurobiology. In J. M. Oldham, A. E. Skodol & D. Bender (Eds.). Textbook of Personality Disorders. American Psychiatric Press: Arlington, VA. pp 155-169.
25. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB et al (1989). Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46: 587-599.
26. Crunelli V, Bernasconi S, Samanin R (1980). Effects of d-and 1-fenfluramine on striatal homovanillic acid concentrations in rats after pharmacological manipulation of brain serotonin. Pharmacol Res Commun 12: 215-223.
27. Di Renzo G, Amoroso S, Taglialatela M, Canzoniero L, Basile V, Fatatis A et al (1989). Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion. Eur J Pharmacol 162: 371.
28. Eysenck SB, Eysenck HJ (1977). The place of impulsiveness in a dimensional system of personality description. Br J Soc Clin Psychol 16(1): 57-68.
29. Fishbein DH, Lozovsky D, Jaffe JH (1989). Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiatry 25: 1049-1066.
30. Frankle WG, Lombardo I, New AS, Goodman M, Talbot PS, Huang Y et al (2005). Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 162(5): 915-923.
31. Garattini S, Bizzi A, Caccia S, Mennini T, Samanin R (1988). Progress in assessing the role of serotonin in the control of food intake. Clin Neuropharmacol 11(Suppl 1): S8-32.
32. Goodall EM, Cowen PJ, Franklin M, Silverstone T (1993). Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharma-cology (Berl) 112(4): 461-466.
33. Halperin JM, Sharma V, Siever LJ, Schwartz ST, Matier K, Wornell G et al (1994). Serotonergic function in aggressive and nonaggressive boys with attention deficit hyperactivity disorder. Am J Psychiatry 151(2): 243-248.
34. Higley JD, Mehlman PT, Taub DM, Higley SB, Suomi SJ, Vickers JH et al (1992). Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Arch Gen Psychiatry 49(6): 436-441.
35. Invernizzi R, Berettera C, Garattini S, Samanin R (1986). d-and l-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 120(1): 9-15.
36. Kessler RC, Coccaro EF, Fava M, Jaeger S, Jin R, Walters E (2006). The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 63(6): 669-678. (Pubitemid 43848298)
37. Krebs HA, Cheng LK, Wright GJ (1984). Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatogr 310(2): 412-417.
38. Kruesi M, Rapoport J, Hamberger S, Hibbs E, Potter W, Lenane M et al (1990). Cerebrospinal fluid metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch Gen Psychiatry 47: 459-462.
39. Limson R, Goldman D, Roy A, Lamparski D, Ravitz B, Adinoff B et al (1991). Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Arch Gen Psychiatry 48(5): 437-441.
40. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK (1983). Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33(26): 2609-2614.
41. Lopez-Ibor JJ, Lana F, Saiz Ruiz J (1990). Conductas autoliticas impulsivas y serotonina. Actas Luso-Esp Neurol Psiquiatr 18: 316-325.
42. Manuck SB, Flory JD, McCaffery JM, Matthews KA, Mann JJ, Muldoon MF (1998). Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology 19(4): 287-299.
43. McCloskey MS, Lee R, Berman ME, Noblett KL, Coccaro EF (2008a). The relationship between impulsive verbal aggression and intermittent explosive disorder. Aggress Behav 34(1): 51-60.
44. McCloskey MS, Noblett KL, Deffenbacher JL, Gollan JK, Coccaro EF (2008b). Cognitive-behavioral therapy for intermittent explosive disorder: a pilot randomized clinical trial. J Consult Clin Psychol 76(5): 876-886.
45. Mitchell PB, Smythe GA (1991). Endocrine and amine responses to D,L-fenfluramine in normal subjects. Psychiatry Res 39(2): 141-153.
46. New AS, Hazlett EA, Buchsbaum MS, Goodman M, Reynolds D, Mitropoulou V et al (2002). Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry 59(7): 621-629.
47. New AS, Trestman RL, Mitropoulou V, Benishay DS, Coccaro E, Silverman J et al (1997). Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res 69(1): 17-26.
48. New AS, Trestman RF, Mitropoulou V, Goodman M, Koenigsberg HH, Silverman J et al (2004). Low prolactin response to fenfluramine in impulsive aggression. J Psychiatr Res 38: 223-230.
49. O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG (1992). Blunted prolactin responses to d-fenfluramine in socio-pathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry 160: 643-646.
50. Park SB, Cowen PJ (1995). Effect of pindolol on the prolactin response to d-fenfluramine. Psychopharmacology (Berl) 118(4): 471-474.
51. Pine DS, Coplan JD, Wasserman GA, Miller LS, Fried JE, Davies M et al (1997). Neuroendocrine response to fenfluramine challenge in boys. Associations with aggressive behavior and adverse rearing. Arch Gen Psychiatry 54: 839-846.
52. Sheard MH, Marini JL, Bridges CI, Wagner E (1976). The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 133: 1409-1413.
53. Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA et al (1999). d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 20: 413-423.
54. Stoff DM, Pastiempo AP, Yeung JH, Cooper TB, Bridger WH, Rabinovich H (1992). Neuroendocrine responses to challenge with d,l-fenfluramine and aggression in disruptive behavior disorders of children and adolescents. Psychiatry Res 43: 263-276.
55. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M (1987). Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry 44(3): 241-247.
56. Westergaard G, Suomi S, Higley J, Mehlman P (1999). CSF 5-HIAA and aggression in female macaque monkeys: Species and interindividual differences. Psychopharmacology 146: 440-444.